The identification and mathematical quantification of the relationship between dose, exposure, and clinical response lies at the core of a successful drug development project. At BAST we have derived such relationships for continuous, categorical, count, time-to-event and repeated time to event clinical endpoints in various disease areas. Thereby we enabled our clients to demonstrate efficacy to regulatory authorities and select meaningful dosing regimens for further clinical development.
Contact us for more information or a quote, if you think that our services will be of help to you!
